ABGABEVORRICHTUNG

European patent · EP4333770 · In force

Register entry

Publication number
EP4333770
Application number
EP22728269
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
May 4, 2022
Published
Mar 13, 2024
Granted
Jul 1, 2026
Protection ends at the latest
May 3, 2042
Next annual fee due
May 31, 2027
IPC classes
A61F 2/24 (2006.01)
A61M 25/01 (2006.01)
A61F 2/95 (2013.01)
A61M 25/06 (2006.01)
A61M 25/00 (2006.01)
Priority
US 202163184403 P 05.05.2021
US 202163184427 P 05.05.2021
PCT application
PCT/IB2022/054099 04.05.2022
PCT publication
WO2022/234468 10.11.2022
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jul 1, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 01.07.2026

Parties

Holder

Innovalve Bio Medical Ltd.

c/o Cardiac Surgery Department 2nd floor Sheba Medical Center Tel Hashomer, 5265601 Ramat-Gan, IL

Inventor

SHIMEL, Guy

6941514 Tel Aviv-Jaffa, IL

AGIAN, Nadav

4030067 Kfar Yona, IL

BAROR, Eyal

7314000 Bet Nehemia, IL

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.